These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12685623)

  • 21. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
    Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of minimum stent cross sectional area as a predictor of angiographic restenosis after primary percutaneous coronary intervention in acute myocardial infarction (from the HORIZONS-AMI Trial IVUS substudy).
    Choi SY; Maehara A; Cristea E; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Lansky AJ; Parise H; Mehran R; Mintz GS; Stone GW
    Am J Cardiol; 2012 Feb; 109(4):455-60. PubMed ID: 22118823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminution in flow following primary stenting in the INAMI study.
    Murphy SA; Gibson CM
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):417; author reply 417-8. PubMed ID: 12822174
    [No Abstract]   [Full Text] [Related]  

  • 25. Does primary stenting preserve cardiac function in myocardial infarction? A case-control study. NORTH-981 investigators. Network of revascularisation therapy in Hokkaido.
    Sasao H; Tsuchihashi K; Hase M; Nakata T; Shimamoto K
    Heart; 2000 Nov; 84(5):515-21. PubMed ID: 11040013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Choi CU; Rha SW; Chen KY; Li YJ; Poddar KL; Jin Z; Minami Y; Suh SY; Na JO; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Circ J; 2009 Dec; 73(12):2229-35. PubMed ID: 19789418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial.
    Antoniucci D; Santoro GM; Bolognese L; Valenti R; Trapani M; Fazzini PF
    J Am Coll Cardiol; 1998 May; 31(6):1234-9. PubMed ID: 9581713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short and intermediate clinical outcome after late coronary stenting in myocardial infarction.
    Uerojanaungkul P; Piamsomboon C; Roongsritong C; Laothavorn P; Naksawasdi C; Sanguanwong S; Tanprasert P
    J Med Assoc Thai; 2001 Jul; 84(7):948-57. PubMed ID: 11759975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary coronary infarct artery stenting in acute myocardial infarction.
    Antoniucci D; Valenti R; Santoro GM; Bolognese L; Trapani M; Moschi G; Fazzini PF
    Am J Cardiol; 1999 Sep; 84(5):505-10. PubMed ID: 10482145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantation.
    Wexberg P; Jordanova N; Strehblow C; Syeda B; Meyer B; Charvat S; Zorn G; Scheinig D; Wojta J; Huber K; Glogar D; Gyöngyösi M
    Thromb Haemost; 2008 Apr; 99(4):739-48. PubMed ID: 18392332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of coronary stenting on restenosis and occlusion after angioplasty of the culprit vessel in patients with recent myocardial infarction.
    Bauters C; Lablanche JM; Van Belle E; Niculescu R; Meurice T; Mc Fadden EP; Bertrand ME
    Circulation; 1997 Nov; 96(9):2854-8. PubMed ID: 9386149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design.
    Hearn JA; King SB; Douglas JS; Carlin SF; Lembo NJ; Ghazzal ZM
    Circulation; 1993 Nov; 88(5 Pt 1):2086-96. PubMed ID: 8222102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.
    Lau HK; Segev A; Hegele RA; Sparkes JD; Teitel JM; Chisholm RJ; Strauss BH
    Thromb Haemost; 2003 Dec; 90(6):1187-91. PubMed ID: 14652655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of balloon pressure inflation in patients undergoing primary coronary stent implantation during acute myocardial infarction. A quantitative coronary angiography analysis.
    Mattos LA; Sousa AG; Chaves A; Feres F; Pinto I; Tanajura L; Centemero M; Abizaid A; Seixas AC; Abizaid A; Maldonado G; Staico R; Sousa JE
    Arq Bras Cardiol; 2003 Mar; 80(3):250-68. PubMed ID: 12856269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
    Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T
    Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study.
    Prisco D; Antonucci E; Fedi S; Margheri M; Giglioli C; Comeglio M; Lombardi A; Chioccioli M; Abbate R; Gensini GF
    Clin Exp Med; 2001 Dec; 1(4):219-24. PubMed ID: 11918281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction.
    Neumann FJ; Kastrati A; Schmitt C; Blasini R; Hadamitzky M; Mehilli J; Gawaz M; Schleef M; Seyfarth M; Dirschinger J; Schömig A
    J Am Coll Cardiol; 2000 Mar; 35(4):915-21. PubMed ID: 10732888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.